Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HIVE2040, officially known as HIVE 2040 R&D LP, is a publicly listed venture capital fund based in Kfar Saba, Israel. Established in 2021 by the Avnon Group and Meitav Dash, the fund operates on the Tel Aviv Stock Exchange under the ticker HIVE:IT. This unique structure allows retail investors to gain exposure to venture capital returns, a rarity in the industry.
The firm focuses on investing in innovative startups within the smart economy and public safety sectors. HIVE2040 aims to support companies that demonstrate rapid growth potential, particularly those that can accelerate towards IPO or M&A exits. The fund's backing from established entities like Avnon and Meitav Dash provides it with significant credibility and resources in the Israeli market.
As of now, HIVE2040 has made three notable investments since its inception, reflecting its commitment to fostering growth in the technology sector. The firm is positioned to leverage its unique public structure to attract a diverse range of investors interested in venture capital opportunities.
HIVE2040 primarily invests in Series A and B startups that are developing products in sectors such as cybersecurity, fintech, IoT, and smart cities. The fund emphasizes investments in companies that exhibit strong growth potential and are positioned to make significant advancements in their respective fields. The typical check size ranges from $2.5 million to $4 million per investment, allowing HIVE2040 to provide substantial support to its portfolio companies.
The firm seeks startups that are not only innovative but also capable of scaling rapidly. HIVE2040's investment thesis focuses on identifying companies that can accelerate towards IPO or M&A exits, ensuring that their investments yield significant returns. This strategic approach is designed to align with the interests of retail investors looking for exposure to high-growth ventures.
HIVE2040 has made three key investments since its establishment, focusing on companies that align with its investment thesis in the smart economy and public safety sectors. The portfolio includes:
These investments reflect HIVE2040's commitment to supporting innovative technologies that address critical challenges in cybersecurity and public safety, showcasing the firm's focus on high-potential sectors.
As of February 2022, HIVE2040 has made notable investments in two companies: NanoLock Security and Viisights. The firm continues to focus on expanding its portfolio within the smart economy and public safety sectors. No recent leadership changes or additional announcements have been reported.
What are HIVE2040's investment criteria?
HIVE2040 invests in Series A and B startups that are developing products in sectors such as cybersecurity, fintech, IoT, and smart cities. The firm looks for companies with strong growth potential and the ability to scale rapidly towards IPO or M&A exits.
How can startups apply or pitch to HIVE2040?
While specific application channels are not publicly disclosed, startups interested in pitching should prepare a comprehensive deck that outlines their business model, market potential, and growth strategy. A warm introduction through industry connections may enhance the chances of securing a meeting.
What makes HIVE2040 different from other venture capital firms?
HIVE2040 is unique in that it is publicly listed on the Tel Aviv Stock Exchange, allowing retail investors to gain exposure to venture capital returns. This structure differentiates it from traditional venture capital firms that typically cater to institutional investors.
What is the geographic focus of HIVE2040?
The firm is based in Kfar Saba, Israel, and primarily invests in Israeli startups, particularly those that are innovating in the smart economy and public safety sectors.
What is the typical check size for investments?
HIVE2040 typically invests between $2.5 million and $4 million per startup, providing substantial capital to support growth and development.
What kind of post-investment involvement does HIVE2040 have?
While specific details on post-investment involvement are not provided, HIVE2040 leverages its backing from established groups like Avnon and Meitav Dash to offer strategic support and guidance to its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.